In addition to patient care, our faculty members conduct both basic and clinical research aimed at developing new treatments for Parkinson’s disease. Some of our faculty conduct clinical trials as members of the Parkinson Study Group, an organization of researchers from the U.S. and Canada who are working to test new treatments for PD, as well as looking into the genetics of people who may be predisposed to develop it. Patients who would like to help in our ongoing research efforts may be able to participate in one of several clinical studies designed to improve medical knowledge about these conditions and to test potential new therapies.
Parkinson Study Group is North America’s largest pro-active, not-for-profit scientific network of Parkinson Centers.
PD GENEration: Mapping the Future of Parkinson’s Disease is a national initiative that offers genetic testing for clinically relevant Parkinson's-related genes and genetic counseling at no cost for people with Parkinson’s disease (PD). Participation can be either in-person at one of our participating Centers of Excellence sites or from home through a telemedicine appointment and at-home cheek swab collection kit.
Breakthroughs that address the health challenges facing our world are at the core of UC Davis Health's mission to discover and share knowledge to advance health. We conduct more than 2,000 research studies at any given time, including basic science, translational, and clinical trial research — all with the goal of bringing new, effective and safe treatments to patients more quickly.
Testing a New Oral Drug to Treat Parkinson's Disease With Dyskinesia
of the sub-thalamic nucleus in Parkinson’s disease
ClinicalTrials.gov is a website and online database of